Funding · Company
Antares Therapeutics, Inc.
Boston, MABiotech & Pharma
Antares Therapeutics, Inc. of Boston, MA has disclosed $70M across 2 Form D offerings filed with the SEC between Mar 12, 2025 and May 15, 2025.
$70M
Total disclosed
2
Form D offerings
2025
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$30M
Form D · May 15, 2025 ↗
Q2 2025
· target $137M
Filing details
HeadquartersBoston, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2025SEC CIK0002059043Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →